• About Us
  • Our Editorial Policy
  • Business Directory
  • Advertise with Us
  • Our Advertisers
  • Contact Us
Australia India News
India News Australia
  • Home
  • Current Issue
    Past Issue
  • India News
  • Politics
  • Business
  • World
    World This Week
  • Community News
  • What's On
  • Others
    Yoga in Australia News COVID-19 Community News Naari IPL News Health Travel Entertainment
  • Migrants Expo
  • National Events
  • Please wait..
Science

108 labs approved for quality testing of Ayurvedic, Siddha and Unani drugs: Minister

  • BY India News Newsdesk
  • December 29, 2025
  • 0 COMMENTS

New Delhi, Dec 29 (IANS) A total of 108 laboratories have been approved for quality testing of Ayurvedic, Siddha and Unani drugs, said Ayush Minister Prataprao Jadhav.

The Minister noted that these labs are approved or licensed under the provisions of the Drugs Rules, 1945

Further, 34 State Drug Testing Laboratories have been supported for strengthening their infrastructural and functional capacity. Three Regional Research Institutions of the Central Council for Research in Ayurveda Sciences are also approved under Rule 160E of the Drugs Rules 1945.

“The Pharmacovigilance Programme for Ayurvedic, Siddha, Unani and Homoeopathy (ASU & H) drugs has been implemented under Central Sector Scheme Ayush Oushadhi Gunavatta Evam Uttpadan Samvardhan Yojana (AOGUSY), which works through a three-tier network of a National Pharmacovigilance Centre (NPvCC), Five Intermediary Pharmacovigilance Centers (IPvCs) and 97 Peripheral Pharmacovigilance Centers (PPvCs) established across the country,” the Minister said.

“These centres are mandated to monitor and report misleading advertisements to the respective State Regulatory Authorities for suitable action against the defaulter,” he added.

The programme aims to keep vigilance over Ayush drugs and to reduce misleading advertisements to ensure consumer protection and prevent the dissemination of unverified claims by Ayush product manufacturers.

“Till date 3,533 awareness programmes have been conducted with 3,18,575 beneficiaries across the country,” Jadhav said.

The Ministry of Ayush also encourages certifications for Ayush products. These include the scheme for Certification of Pharmaceutical Product (CoPP) as per World Health Organization (WHO) guidelines; the quality certifications scheme implemented by the Quality Council of India (QCI).

The Central sector scheme AOGUSY has been implemented with a total financial allocation of Rs 122.00 crores for five years from 2021-22 to 2025-26. One of the components of this scheme is to strengthen and upgrade Ayush Pharmacies and Drug Testing Laboratories to achieve higher standards.

–IANS

rvt/

Post navigation

Biz lobbies urge AI-led growth, stronger public-private cooperation in 2026
Terrorists take unusual winter risk in J&K, agencies flag shift in pattern

Related Post

Over 900 suspected cases identified in Congo Ebola response: WHO chief
May 25, 2026
Bangladesh measles outbreak death toll rises to 528 after 16 more fatalities
May 25, 2026
Andhra Pradesh’s Chityala records season’s highest temperature at 48.3 degrees Celsius
May 25, 2026
Burkina Faso strengthens preventive measures against Ebola
May 25, 2026

Our Current Issue

Australia IA – May 16-31, 2026

Alluring India 2026

Alluring India 2026

Our Advertisers

  • Battery Rebate australia
  • Bess Australia Solar Panels

Follow Us

  • facebook
  • facebook
  • facebook
  • facebook
INDIA NEWS on YouTube in Australia, bring to our readers and subscribers national and international news, editorials, expert columns, community activities and interviews of political leaders, celebrities, business professionals, academics and sport personalities among others.
  • facebook
  • facebook
  • facebook
  • facebook

Category

  • Accident
  • Adani Australia
  • Advertorial
  • Arts & Culture
  • Ashes 2022
  • Australia

Recent News

  • Marco Rubio in Jaipur today, traffic restrictions...
  • Nashik TCS harassment case: Police issue summons...

Subscribe Newsletter

Get the latest creative news from india news

  • Privacy Policy
  • Disclaimer